Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
To determine the relative abuse potential of VYCAVERT (hydrocodone bitartrate and
acetaminophen) compared to GENERIC H/A (hydrocodone bitartrate and acetaminophen) when
crushed and administered intranasally to non dependent, recreational opioid users.
Phase:
Phase 2
Details
Lead Sponsor:
Acura Pharmaceuticals Inc.
Treatments:
Acetaminophen Acetaminophen, hydrocodone drug combination Hydrocodone Oxycodone